Success Metrics

Clinical Success Rate
90.1%

Based on 201 completed trials

Completion Rate
90%(201/223)
Active Trials
98(25%)
Results Posted
17%(35 trials)
Terminated
22(6%)

Phase Distribution

Ph early_phase_1
2
1%
Ph not_applicable
92
23%
Ph phase_1
15
4%
Ph phase_3
6
2%
Ph phase_2
12
3%
Ph phase_4
14
4%

Phase Distribution

17

Early Stage

12

Mid Stage

20

Late Stage

Phase Distribution141 total trials
Early Phase 1First-in-human
2(1.4%)
Phase 1Safety & dosage
15(10.6%)
Phase 2Efficacy & side effects
12(8.5%)
Phase 3Large-scale testing
6(4.3%)
Phase 4Post-market surveillance
14(9.9%)
N/ANon-phased studies
92(65.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.0%

201 of 245 finished

Non-Completion Rate

18.0%

44 ended early

Currently Active

98

trials recruiting

Total Trials

399

all time

Status Distribution
Active(110)
Completed(201)
Terminated(44)
Other(44)

Detailed Status

Completed201
Recruiting71
unknown42
Active, not recruiting27
Withdrawn22
Terminated22

Development Timeline

Analytics

Development Status

Total Trials
399
Active
98
Success Rate
90.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.4%)
Phase 115 (10.6%)
Phase 212 (8.5%)
Phase 36 (4.3%)
Phase 414 (9.9%)
N/A92 (65.2%)

Trials by Status

withdrawn226%
completed20150%
active_not_recruiting277%
terminated226%
not_yet_recruiting92%
recruiting7118%
enrolling_by_invitation31%
unknown4211%
suspended21%

Recent Activity

Clinical Trials (399)

Showing 20 of 399 trialsScroll for more
NCT02743858

Lymphedema Surveillance Study

Recruiting
NCT04331067Phase 1

Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer

Active Not Recruiting
NCT03874559

Exosomes in Rectal Cancer

Recruiting
NCT07570407

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

Not Yet Recruiting
NCT05036707Phase 1

Human Immune Response to Ixodes Scapularis Tick Bites

Recruiting
NCT06688825Not Applicable

Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program

Recruiting
NCT06127979Not Applicable

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

Recruiting
NCT07474779Not Applicable

Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging

Not Yet Recruiting
NCT04906863

Genetic Studies of Early-onset Dementia

Recruiting
NCT01385176Not Applicable

Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)

Active Not Recruiting
NCT00898313

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

Recruiting
NCT02630615

Circulating Tumor Cells (CTC) in Lung Cancer

Active Not Recruiting
NCT07046936

Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer

Recruiting
NCT06660108Not Applicable

MOLECULAR BASIS OF LANGUAGE DEVELOPMENT AND ASSOCIATED DISORDERS

Recruiting
NCT06908057

Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)

Active Not Recruiting
NCT04406831

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

Recruiting
NCT07518784

Accurate Point of Care Liver Disease Diagnostics (Phase 2)

Recruiting
NCT05899439

Immune Function and the Progression to T1D

Recruiting
NCT02087852

Kidney Cancer DNA Registry

Recruiting
NCT04067726Phase 2

RANKL Inhibition and Mammographic Breast Density

Active Not Recruiting

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
399